Evergy Inc. Common Stock vs IDEXX Laboratories, Inc. — how do they compare? Evergy Inc. Common Stock trades at $80.92 (market cap $18.57B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.2× Evergy Inc. Common Stock's market cap, and Evergy Inc. Common Stock pays a 3.45% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Evergy Inc. Common Stock for 1 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EVRG | IDXX | |
|---|---|---|
Market Cap | $18.57B | $40.43B |
Volume | 1,988,675 | 692,164 |
Sector | Utilities | Health |
52-Week High | $88.13 | $766.68 |
52-Week Low | $72.31 | $504.70 |
Typical Hold Time | 1 Days | 46 Days |
Enterprise Value | $35.04B | $41.32B |
Dividend Yield | 3.45% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Trailing returns across standard periods
Evergy is a regulated electric utility serving customers in Kansas and Missouri. Its operations include electricity generation, transmission, and distribution through its integrated utility subsidiaries.
Read more on EVRG →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →